BlackRock Health Sciences Term Trust (NYSE:BMEZ) to Issue Monthly Dividend of $0.11

Posted by Brenda Bartman on Jul 13th, 2026

BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) announced a monthly dividend on Friday, June 5th. Investors of record on Wednesday, July 15th will be paid a dividend of 0.11 per share on Friday, July 31st. This represents a c) annualized dividend and a yield of 8.5%. The ex-dividend date is Wednesday, July 15th.

BlackRock Health Sciences Term Trust Stock Performance

NYSE:BMEZ opened at $15.46 on Monday. BlackRock Health Sciences Term Trust has a fifty-two week low of $13.67 and a fifty-two week high of $15.80. The company has a fifty day moving average of $14.60 and a two-hundred day moving average of $14.72.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of BMEZ. Baird Financial Group Inc. purchased a new position in BlackRock Health Sciences Term Trust in the 1st quarter valued at about $189,000. Geneos Wealth Management Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust in the first quarter valued at approximately $40,000. NewEdge Advisors LLC boosted its stake in shares of BlackRock Health Sciences Term Trust by 134.3% in the second quarter. NewEdge Advisors LLC now owns 48,300 shares of the company’s stock worth $689,000 after acquiring an additional 27,686 shares during the last quarter. Jane Street Group LLC increased its position in shares of BlackRock Health Sciences Term Trust by 157.1% during the second quarter. Jane Street Group LLC now owns 97,472 shares of the company’s stock worth $1,390,000 after purchasing an additional 59,559 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its stake in BlackRock Health Sciences Term Trust by 14.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 14,521 shares of the company’s stock valued at $212,000 after purchasing an additional 1,787 shares during the last quarter.

BlackRock Health Sciences Term Trust Company Profile

(Get Free Report)

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.